Ftse Mib
34.089,21
1,04%
DAX
19.963,98
0,63%
S&P 500
5.954,58
-1,37%
NASDAQ
19.656,92
-1,82%
Bitcoin
94.182,23
-1,57%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Medicinova Inc (MNOV) Medicinova Inc (MNOV) Notizie

Medicinova Inc

MNOV
2,0638
0,1138 (5,84%)
Ultimo aggiornamento: 16:46:18
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/12/202400:00GLOBEMediciNova Presents Study Update and Interim Analysis of..
19/11/202415:00GLOBEMediciNova CEO Yuichi Iwaki Provides Corporate Update in..
15/11/202400:00GLOBEMediciNova Receives Notice of Allowance from United States..
13/11/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202400:00GLOBEMediciNova Given Notice of Monetary Damages Due Under Patent..
24/10/202401:00GLOBEMediciNova Announces Update of Phase 2/3 Clinical Trial of..
30/9/202415:00GLOBEMediciNova to Support NIH-Funded Expanded Access Clinical..
10/9/202401:00GLOBEMediciNova Announces Abstract Regarding MN-166 (ibudilast)..
04/9/202401:00GLOBEMediciNova Announces Acceptance of Abstract Regarding MN-166..
30/8/202401:00GLOBEMediciNova Receives Notice of Allowance from United States..
08/8/202422:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/6/202412:00GLOBEMediciNova Chief Business Officer David H. Crean, Ph.D...
13/6/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:15EDGAR2Form 8-K - Current report
05/6/202412:00GLOBEMediciNova Receives Notice of Allowance for New Patent..
03/6/202412:00GLOBEMediciNova Announces Data from Phase 1b/2a Clinical Trial of..
28/5/202412:00GLOBEMediciNova Announces Two Poster Presentations at the 92nd..
20/5/202412:00GLOBEMediciNova Receives Notice of Allowance for New Patent..
14/5/202412:00GLOBEMediciNova Receives Notice of Allowance for New Patent..
09/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202412:00GLOBEMediciNova Receives Issue Notification for New Patent..
03/4/202401:00GLOBEMediciNova Announces Abstract Regarding Results of a..
27/3/202400:00GLOBEMediciNova Receives a Notice of Allowance for a New Patent..
21/3/202400:00GLOBEMediciNova Announces Two Abstracts regarding MN-001..
12/3/202411:30GLOBEMediciNova Announces New Data and Results of MN-166..
15/2/202422:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
19/1/202422:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202422:25EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202422:23EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202422:21EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/1/202412:00GLOBEMediciNova Receives a Notice of Grant for a New Patent..
11/1/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,03 Min: 2,03 Max: 2,1395
Chiusura: 1,95

La tua Cronologia

NASDAQ
MNOV
Medicinova
NASDAQ
FDPBX
Bmo Global Low Volatilit...
BIT
A33666
Aldburg Public
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network